Urotensin II receptor predicts the clinical outcome of prostate cancer patients and is involved in the regulation of motility of prostate adenocarcinoma cells.
about
The G Protein-Coupled Receptor UT of the Neuropeptide Urotensin II Displays Structural and Functional Chemokine Features.Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion.The relationship between urotensin II and its receptor and the clinicopathological parameters of breast cancer.Acting on Hormone Receptors with Minimal Side Effect on Cell Proliferation: A Timely Challenge Illustrated with GLP-1R and GPERIncreased expression of urotensin II is associated with poor prognosis in hepatocellular carcinomaLong non-coding RNA MALAT1 drives gastric cancer progression by regulating HMGB2 modulating the miR-1297.Urotensin II receptor on preoperative biopsy is associated with upstaging and upgrading in prostate cancer.Urotensin-II receptor is over-expressed in colon cancer cell lines and in colon carcinoma in humans.Chemotactic G protein-coupled receptors control cell migration by repressing autophagosome biogenesis.Urotensin II receptor as a potential biomarker for the prognosis of hepatocellular carcinoma patients.A new therapeutic approach to erectile dysfunction: urotensin-II receptor high affinity agonist ligands.Signaling switch of the urotensin II vasosactive peptide GPCR: prototypic chemotaxic mechanism in glioma.
P2860
Q33599835-88EE1DEF-CE68-45A8-951E-488AB371AD43Q33772333-F914F78D-5E5E-4BCF-BDE6-42489E44503CQ34066190-EBF05811-2268-42DF-8DB6-A8078F943FDDQ36800401-08BDA924-DC4B-4CB7-B25A-7500196B692AQ37582059-B8D09EA9-1603-4224-929B-5EDCE128F7FCQ37740977-F7ADD5A1-4282-40FA-8DEE-3E84DAA1D604Q38588658-98FF0D94-8725-465F-9394-2258AE63F207Q39039151-EFA15A10-1F93-4911-8570-E06FF8A83E64Q39313143-6D174D3A-D244-4FEE-8827-C836E19EFA68Q41613067-7DCC7C99-8401-4567-8916-B7A2466CF8E1Q42139903-AAFDF95D-16FB-42D1-AD34-AE93BE4418B6Q48372089-07D220C4-F6DA-4F2C-8781-C5B6F960AB67
P2860
Urotensin II receptor predicts the clinical outcome of prostate cancer patients and is involved in the regulation of motility of prostate adenocarcinoma cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Urotensin II receptor predicts ...... prostate adenocarcinoma cells.
@en
Urotensin II receptor predicts ...... prostate adenocarcinoma cells.
@nl
type
label
Urotensin II receptor predicts ...... prostate adenocarcinoma cells.
@en
Urotensin II receptor predicts ...... prostate adenocarcinoma cells.
@nl
prefLabel
Urotensin II receptor predicts ...... prostate adenocarcinoma cells.
@en
Urotensin II receptor predicts ...... prostate adenocarcinoma cells.
@nl
P2093
P2860
P50
P356
P1476
Urotensin II receptor predicts ...... prostate adenocarcinoma cells.
@en
P2093
Achille Cittadini
Laura Toccacieli
Luigi Gallo
Luigi Marra
Monica Marra
Paolo Grieco
Silvia Zappavigna
Stefano Striano
P2860
P304
P356
10.1002/JCB.22933
P50
P577
2011-01-01T00:00:00Z